Stay updated on IPF/ILD-PRO Clinical Trial of Novel Therapy
Sign up to get notified when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.

Latest updates to the IPF/ILD-PRO Clinical Trial of Novel Therapy page
- ChecktodayChange DetectedNew publication added to the Publications section: 'Mass spectrometry-based peripheral blood proteomics for biomarker discovery in idiopathic pulmonary fibrosis' (Respir Res. 2025 Oct 22;26(1):294). This minor update does not affect study details, eligibility, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0% 
- Check8 days agoChange DetectedUpdated recruitment status and contact details with new dates and contacts; older status notes and older update timestamp removed.SummaryDifference1% 
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2% 
- Check29 days agoChange DetectedExpanded contact information added (numerous names, emails, and phone numbers) with a page revision update to v3.1.0; previous v3.0.2 is removed.SummaryDifference0.1% 
- Check44 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; removed the 'Back to Top' element.SummaryDifference0.1% 
- Check51 days agoChange DetectedThe page has updated the citation for a study on lung function and mortality risk in patients with idiopathic pulmonary fibrosis, reflecting a change in the publication date and version number.SummaryDifference0.6% 
Stay in the know with updates to IPF/ILD-PRO Clinical Trial of Novel Therapy
Enter your email address, and we'll notify you when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.